Stock CNTG CENTOGENE N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.5151 USD +3.02% Intraday chart for Centogene N.V. +16.54% -57.08%
Jun. 20 Critical Path Institute and Centogene N.V. Announces the Signing of A Memorandum of Understanding to Advance Drug Development for Lysosomal Diseases CI
May. 16 Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday MT

Evolution of the average Target Price on Centogene N.V.

Price target over the last 5 years

History of analyst recommendation changes

d8ed35dfee7e62231b87e65a9c24f612._4G1OG7jZgIYiG2m1wr2ksgWtRUuZnTo5nAhX7lS-iI.hsP0YF7RPDt2xz70mDq83K1k_39PHwyH3yJrPIhhvRecxfMLKZQUZ3fGLA~8211bdbc1856cd0252087f4d089a2b2f

Analyst Recommendations on Centogene N.V.

HC Wainwright Trims Price Target on Centogene to $1.50 From $2.50, Keeps Buy Rating MT
HC Wainwright Reiterates Centogene N.V at Buy With $2.50 Price Target MT
HC Wainwright Starts Centogene at Buy With $2.50 Price Target MT
SVB Securities Adjusts Centogene's Price Target to $6 from $10, Keeps Outperform Rating MT
Kempen Downgrades Centogene N.V to Neutral From Buy, Adjusts Target Price to $5.50 From $22 MT
BTIG Adjusts Centogene's Price Target to $18 From $23, Reiterates Buy Rating MT
CENTOGENE N : Baird Adjusts Centogene's Price Target to $15 from $17, Keeps Outperform Rating MT
CENTOGENE N : Credit Suisse Lowers Centogene's PT to $14 from $15 After Weaker-than-Expected Q1 Profitability, Keeps Outperform Rating MT
CENTOGENE N : Credit Suisse Starts Centogene at Outperform with $15 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.4723 EUR
Average target price
1.378 EUR
Spread / Average Target
+191.73%
High Price Target
1.378 EUR
Spread / Highest target
+191.73%
Low Price Target
1.378 EUR
Spread / Lowest Target
+191.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Centogene N.V.

HC Wainwright
SVB Securities LLC
Kempen
BTIG
Baird
Credit Suisse

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CNTG Stock
  4. Consensus Centogene N.V.